檢索結果 - Michael Oertel
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma 由 Niklas Benedikt Pepper, Hans Theodor Eich, Michael Müther, Michael Oertel, Stephan Rehn, Dorothee Cäcilia Spille, Walter Stummer
發表在 Radiation Oncology (2024-01-01)獲取全文
Article -
6
-
7
-
8
Activation of WNT/Beta‐Catenin Signaling and Regulation of the Farnesoid X Receptor/Beta‐Catenin Complex After Murine Bile Duct Ligation 由 Rong Zhang, Toshimasa Nakao, Jing Luo, Yuhua Xue, Pamela Cornuet, Michael Oertel, Karis Kosar, Sucha Singh, Kari Nejak‐Bowen
發表在 Hepatology Communications (2019-12-01)獲取全文
Article -
9
-
10
Inhibiting Wnt Signaling Reduces Cholestatic Injury by Disrupting the Inflammatory AxisSummary 由 Mary Ayers, Karis Kosar, Yuhua Xue, Chhavi Goel, Matthew Carson, Elizabeth Lee, Silvia Liu, Eva Brooks, Pamela Cornuet, Michael Oertel, Bharat Bhushan, Kari Nejak-Bowen
發表在 Cellular and Molecular Gastroenterology and Hepatology (2023-01-01)獲取全文
Article -
11
Prognostic marker Musashi-2 modulates DNA damage response and radioresistance in diffuse large B-cell lymphoma 由 Timo Habig, Lasse Reichstein, Kathrin A. Brücksken, Mark Sicking, Jan Labisch, Michael Oertel, Eberhard Korsching, Georg Lenz, Stephan Hailfinger, Burkhard Greve, Fabian M. Troschel, Hans Theodor Eich
發表在 Frontiers in Cell and Developmental Biology (2025-08-01)獲取全文
Article -
12
P097: The status quo of involved-field radiotherapy – Quality analysis of radiotherapy in the GHSG HD 16 由 Michael Oertel, Dominik Hering, Christopher Kittel, Nina Nacke, Kai Kröger, Jan Kriz, Michael Fuchs, Christian Baues, Dirk Vordermark, Rita Engenhart-Cabillic, Klaus Herfarth, Peter Lukas, Heinz Schmidberger, Simone Marnitz, Peter Borchmann, Uwe Haverkamp, Andreas Engert, Hans Theodor Eich
發表在 HemaSphere (2022-10-01)獲取全文
Article -
13
P093: From involved- field to involved-node – Quality analysis of the radiation therapy in HD 17 by the expert panel of the German Hodgkin Study Group 由 Michael Oertel, Dominik Hering, Nina Nacke, Christopher Kittel, Kai Kröger, Jan Kriz, Michael Fuchs, Christian Baues, Dirk Vordermark, Rita Engenhart-Cabillic, Klaus Herfarth, Peter Lukas, Heinz Schmidberger, Simone Marnitz, Peter Borchmann, Andreas Engert, Uwe Haverkamp, Hans Theodor Eich
發表在 HemaSphere (2022-10-01)獲取全文
Article -
14
P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial 由 Michael Oertel, Dominik Hering, Nina Nacke, Christopher Kittel, Kai Kröger, Jan Kriz, Michael Fuchs, Christian Baues, Dirk Vordermark, Rita Engenhart-Cabillic, Klaus Herfarth, Peter Lukas, Heinz Schmidberger, Simone Marnitz, Peter Borchmann, Andreas Engert, Uwe Haverkamp, Hans Theodor Eich
發表在 HemaSphere (2022-10-01)獲取全文
Article
